Holen Sie sich die Stockscreener-App
11.35
6.51%
-0.79
Vorhandelsmarkt:
11.42
0.07
+0.62%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Finanzdaten der Sellas Life Sciences Group Inc-Aktie (SLS)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Cost Of Revenue |
-
|
- | - | - | - |
| Costs And Expenses |
14.88%
10.63
|
9.252 | 8.255 | 7.083 | 6.873 |
| Operating Income/Loss |
14.88%
-10.63
|
-9.252 | -8.255 | -7.083 | -6.873 |
| Nonoperating Income/Loss |
21.18%
1.024
|
0.845 | 0.597 | 0.292 | 0.272 |
| Net Income/Loss |
14.25%
-9.605
|
-8.407 | -7.658 | -6.791 | -6.601 |
| Basic Average Shares |
9.68%
189.18
|
172.48 | - | 108.40 | 98.56 |
| Diluted Average Shares |
9.68%
189.18
|
172.48 | - | 108.40 | 98.56 |
| Basic Earnings Per Share |
0.00%
-0.05
|
-0.05 | - | -0.06 | -0.07 |
| Diluted Earnings Per Share |
0.00%
-0.05
|
-0.05 | - | -0.06 | -0.07 |
3.18%
2.54%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):